Aquarius Surgical Technologies Inc.
ASTI
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | -33.37% | -58.36% | -53.63% | -56.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | -33.37% | -58.36% | -53.63% | -56.73% |
| Cost of Revenue | -3.79% | -35.81% | -59.47% | -38.60% | -40.86% |
| Gross Profit | 3.51% | -31.08% | -57.36% | -61.66% | -65.35% |
| SG&A Expenses | -48.28% | -49.57% | -21.33% | -19.16% | -7.45% |
| Depreciation & Amortization | -46.19% | -27.27% | -12.89% | -12.61% | -8.30% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.13% | -47.61% | -25.07% | -20.58% | -10.96% |
| Operating Income | 52.64% | 50.22% | 15.26% | 9.44% | -8.20% |
| Income Before Tax | 43.99% | -25.55% | 6.53% | 73.18% | -49.87% |
| Income Tax Expenses | 309.09% | 7.69% | 7.69% | -78.85% | -83.58% |
| Earnings from Continuing Operations | 43.52% | -25.41% | 6.41% | 73.23% | -48.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.52% | -25.41% | 6.41% | 73.23% | -48.31% |
| EBIT | 52.64% | 50.22% | 15.26% | 9.44% | -8.20% |
| EBITDA | 53.41% | 50.50% | 15.29% | 9.29% | -8.85% |
| EPS Basic | 43.56% | -25.42% | 6.19% | 72.64% | -49.26% |
| Normalized Basic EPS | 22.70% | 26.80% | 5.71% | -1.50% | -11.90% |
| EPS Diluted | 43.56% | -25.42% | 6.19% | 72.64% | -49.26% |
| Normalized Diluted EPS | 22.70% | 26.80% | 5.71% | -1.50% | -11.90% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |